Russia’s Federal Medical Biological Agency begins clinical trials of medicines to treat coronavirus-induced pneumonias, the agency’s chief, Veronika Skvortsova said on April 6. “Taking into account the good acceptability and safety of the Dalargin drug it demonstrated during the registration study, the Federal Medical Biological Agency begins its clinical trials in the treatment of acute coronavirus pneumonias associated with breathing problems posing acute respiratory distress syndrome risks,” she said... Full text GMPnews.Net
Russia’s Federal Medical Biological Agency begins clinical trials of medicines to treat coronavirus-induced pneumonias, the agency’s chief, Veronika Skvortsova said on April 6.
“Taking into account the good acceptability and safety of the Dalargin drug it demonstrated during the registration study, the Federal Medical Biological Agency begins its clinical trials in the treatment of acute coronavirus pneumonias associated with breathing problems posing acute respiratory distress syndrome risks,” she said...
Full text GMPnews.Net